Topic Hub
5 clinically reviewed articles, written and peer-reviewed by the HealthRX Medical Team.
Explore
Showing 5 of 5 clinical reviews.
A detailed review of modafinil's FDA approval history, international scheduling, labeled indications, and post-market safety actions across the US, EU, UK, Australia, and other major markets.
Read clinical reviewA physician-reviewed analysis of FDA Adverse Event Reporting System (FAERS) safety signals for Provigil (modafinil), including serious skin reactions, psychiatric events, and cardiovascular reports.
Read clinical reviewA complete timeline of Provigil (modafinil) FDA approval, label revisions, post-market safety actions, and current regulatory status for narcolepsy, OSA, and shift-work disorder.
Read clinical reviewA clinical guide to the FDA regulatory status of modafinil (Provigil), its compounding eligibility under federal law, and what prescribers should understand about 503A and 503B pathways.
Read clinical reviewA clinical review of the modafinil regulatory timeline, current generic market, and next-generation wakefulness-promoting agents in development or recently approved.
Read clinical review